Evidence map›Paper›PMID 29098530›Full record

ArticleNeurochemical research2018

Adiponectin Attenuates Streptozotocin-Induced Tau Hyperphosphorylation and Cognitive Deficits by Rescuing PI3K/Akt/GSK-3β Pathway.

Zhi-Peng Xu, Guo-Sheng Gan, Yu-Min Liu, Jin-Song Xiao, Han-Xing Liu, Bin Mei, Jun-Jian Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Skeletal Muscle as Endocrine Organ.Advances in experimental medicine and biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Major Depressive Disorder and Gut Microbiota: Role of Physical Exercise.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zhi-Peng XuDepartment of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China.
Guo-Sheng GanDepartment of Anesthesiology, Wuhan General Hospital of PLA, Wuhan, 430070, China.
Yu-Min LiuDepartment of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China.
Jin-Song XiaoDepartment of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China.
Han-Xing LiuDepartment of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China.
Bin MeiDepartment of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China.
Jun-Jian ZhangDepartment of Neurology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China. wdsjkx@163.com.
Wuhan University · CNZhongnan Hospital of Wuhan University · CNWuhan General Hospital of Guangzhou · CN

Funding

Natural Science Foundation of Hubei Province of China 2014CFB223
6 · The paper itself

Abstract

Clinical studies have demonstrated that decreased adiponectin is associated with the development of Type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD). We focused on determining the neuroprotective effect offered by adiponectin against streptozotocin-induced brain damage in ICV-STZ rat model. We found that adiponectin supplements significantly restored the cognitive deficits in ICV-STZ rat model including shorter escape latency, more crossing times and increased time spent in the target quadrant. Adiponectin supplements also increased number of dendritic branches and mushroom percentage. In addition, adiponectin supplements attenuated tau hyperphosphorylation at multiple AD-related sites through activation of protein Ser9-phosphorylated glycogen synthase kinase-3β (Ser9-GSK-3β) with increased the Akt and PI3K activity. Our data suggest that adiponectin supplements have neuroprotective effects on the ICV-STZ rat model, which may be mediated by the activation of the PI3K/Akt/GSK-3β signaling pathway.

Indexed as

AdiponectinAnimalsCognition DisordersGlycogen Synthase Kinase 3 betaMaleNeuronsNeuroprotective AgentsPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktRats, Sprague-DawleyStreptozocintau ProteinsAdiponectinGlycogen Synthase Kinase 3 betaNeuroprotective AgentsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktStreptozocintau ProteinsAdiponectinAlzheimer’s diseaseGlycogen synthase kinase-3β

Identifiers

PMID29098530
OpenAlexW2765995028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.